(2004) demonstrated that epithalamin can increase melatonin production in healthy elderly human subjects, via the peptides modulation of the pineal glands melatonin-producing function [7]
Pelicano H, Carney D, Huang P
No acute effects of exogenous glucose-dependent insulinotropic polypeptide on energy intake, appetite, or energy expenditure when added to treatment with a long-acting glucagon-like peptide 1 receptor agonist in men with type 2 diabetes
These numbers matter because GLP-1s slow down digestion and change gut motility, which is why side effects like nausea, constipation, diarrhea, bloating, and gas are so common
Liu, X.X
The phase 3 TRIUMPH-4 data showed these rates at 9 mg and 12 mg doses respectively: Nausea: 38.1% and 43.2% (vs 10.7% placebo) Diarrhea: 34.7% and 33.1% (vs 13.4% placebo) Constipation: 21.8% and 25.0% (vs 8.7% placebo) Vomiting: 20.4% and 20.9% (vs placebo) These numbers are higher than cagrilintide monotherapy across the board